Request Legal Help Now - Free


Phosphocol P 32 Linked to Risk Of Leukemia In Children

Off-Label Use of the Drug for Intra-articular Injections the Cause

The Food and Drug Administration has issued a Safety Alert regarding the unapproved use of Phosphocol P 32 (Chromic Phosphate P 32 Suspension) in children.

Two children with hemophilia, aged 9 and 14, who were treated with the drug developed acute lymphocytic leukemia with within one year following intra-articular injections. Phosphocol P 32 is not approved for use for intra-articular injection, or treating bleeding between the joints that is caused by hemophilia. The product labeling has been revised to warn health care professionals of this risk.

SEPT-19-08: Phosphocol P 32- Risk Of Leukemia Associated With Off-Label Intra-articular Use In Children [FDA: PHOSPHOCOL P 32 ]

Legal Help

If you or a loved one has suffered ill health or injury as a result of exposure to this drug, please click the link below to send your complaint to a lawyer to evaluate your claim at no cost or obligation.
Published on Sep-19-08


Fields marked * are mandatory. Please read our comment guidelines before posting.


Note: Your name will be published with your comment.

*Email Address:

Your email will only be used if a response is needed.
*Your Comment:

Are you the defendant or a subject matter expert on this topic with an opposing viewpoint? We'd love to hear your comments here as well, or if you'd like to contact us for an interview please submit your details here.

Request Legal Help Now! - Free